发明名称 DRY POWDER FOR INHALATION
摘要 <P>PROBLEM TO BE SOLVED: To improve the moisture resistance of dry powder formulations for inhalation and to improve the storage stability of the formulations. <P>SOLUTION: For improving the moisture resistance of dry powder formulations for inhalation and improving the storage stability of the formulations, the formulations contain a phamaceutically not effective carrier of not-inhalable particle size and a finely divided phamaceutically effective substance of inhalable particle size. For the improvement, magnesium stearate is used in the formulations. One of the features of the inventive dry powder is that a high fine particle dosage or fine particle fraction can be maintained under relatively extreme temperature and humidity conditions. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011231124(A) 申请公布日期 2011.11.17
申请号 JP20110161143 申请日期 2011.07.22
申请人 JAGOTEC AG 发明人 KELLER MANFRED;MUELLER-WALZ RUDI
分类号 A61K47/12;A61K;A61K9/00;A61K9/12;A61K9/14;A61K9/72;A61K31/135;A61K31/137;A61K31/138;A61K31/15;A61K31/167;A61K31/19;A61K31/192;A61K31/20;A61K31/221;A61K31/235;A61K31/27;A61K31/341;A61K31/352;A61K31/357;A61K31/381;A61K31/40;A61K31/404;A61K31/41;A61K31/4164;A61K31/4178;A61K31/42;A61K31/435;A61K31/4355;A61K31/437;A61K31/439;A61K31/44;A61K31/451;A61K31/46;A61K31/47;A61K31/485;A61K31/4965;A61K31/519;A61K31/522;A61K31/551;A61K31/5517;A61K31/569;A61K31/573;A61K31/58;A61K38/00;A61K38/11;A61K38/22;A61K38/24;A61K38/28;A61K45/00;A61K47/10;A61K47/26;A61K47/34;A61K47/40;A61M11/00;A61P29/00;A61P43/00 主分类号 A61K47/12
代理机构 代理人
主权项
地址